BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15095219)

  • 1. Vaccinate against aspergillosis! A call to arms of the immune system.
    Stevens DA
    Clin Infect Dis; 2004 Apr; 38(8):1131-6. PubMed ID: 15095219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a vaccine for invasive aspergillosis.
    Sheppard DC; Edwards JE
    Clin Infect Dis; 2004 Apr; 38(8):1137-8. PubMed ID: 15095220
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccination of corticosteroid immunosuppressed mice against invasive pulmonary aspergillosis.
    Ito JI; Lyons JM
    J Infect Dis; 2002 Sep; 186(6):869-71. PubMed ID: 12198627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune sensing of Aspergillus fumigatus proteins, glycolipids, and polysaccharides and the impact on Th immunity and vaccination.
    Bozza S; Clavaud C; Giovannini G; Fontaine T; Beauvais A; Sarfati J; D'Angelo C; Perruccio K; Bonifazi P; Zagarella S; Moretti S; Bistoni F; Latgé JP; Romani L
    J Immunol; 2009 Aug; 183(4):2407-14. PubMed ID: 19625642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Toll-like receptors in lung innate defense against invasive aspergillosis. Distinct impact in immunocompetent and immunocompromized hosts.
    Chignard M; Balloy V; Sallenave JM; Si-Tahar M
    Clin Immunol; 2007 Sep; 124(3):238-43. PubMed ID: 17604224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination studies of aspergillosis in turkeys: subcutaneous inoculation with several vaccine preparations followed by aerosol challenge exposure.
    Richard JL; Thurston JR; Cutlip RC; Pier AC
    Am J Vet Res; 1982 Mar; 43(3):488-92. PubMed ID: 7041709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccinations with recombinant variants of Aspergillus fumigatus allergen Asp f 3 protect mice against invasive aspergillosis.
    Ito JI; Lyons JM; Hong TB; Tamae D; Liu YK; Wilczynski SP; Kalkum M
    Infect Immun; 2006 Sep; 74(9):5075-84. PubMed ID: 16926399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses to Aspergillus fumigatus infections.
    Rivera A; Hohl T; Pamer EG
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):47-9. PubMed ID: 16399584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell vaccination in mice with invasive pulmonary aspergillosis.
    Cenci E; Mencacci A; Bacci A; Bistoni F; Kurup VP; Romani L
    J Immunol; 2000 Jul; 165(1):381-8. PubMed ID: 10861075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of protection against challenge with aspergillus fumigatus by adoptive transfer of splenocytes from convalescent turkeys.
    Kunkle RA; Rimler RB; Steadham EM
    Avian Dis; 1999; 43(4):678-84. PubMed ID: 10611984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspergillus fumigatus: contours of an opportunistic human pathogen.
    McCormick A; Loeffler J; Ebel F
    Cell Microbiol; 2010 Nov; 12(11):1535-43. PubMed ID: 20716206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of macrophages in host defense against aspergillosis and strategies for immune augmentation.
    Segal BH
    Oncologist; 2007; 12 Suppl 2():7-13. PubMed ID: 18039634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective role of mannan-binding lectin in a murine model of invasive pulmonary aspergillosis.
    Kaur S; Gupta VK; Thiel S; Sarma PU; Madan T
    Clin Exp Immunol; 2007 May; 148(2):382-9. PubMed ID: 17335555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis.
    Alvarez CA; Wiederhold NP; McConville JT; Peters JI; Najvar LK; Graybill JR; Coalson JJ; Talbert RL; Burgess DS; Bocanegra R; Johnston KP; Williams RO
    J Infect; 2007 Jul; 55(1):68-74. PubMed ID: 17360039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine progress.
    Ito JI; Lyons JM; Diaz-Arevalo D; Hong TB; Kalkum M
    Med Mycol; 2009; 47 Suppl 1():S394-400. PubMed ID: 19247869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination approaches against opportunistic fungal infections caused by Aspergillus fumigatus.
    Reichard U; Herrmann S; Asif AR
    Curr Protein Pept Sci; 2014; 15(5):424-9. PubMed ID: 24818757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects of vaccines for invasive aspergillosis.
    Feldmesser M
    Med Mycol; 2005 Nov; 43(7):571-87. PubMed ID: 16396243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of adjuvant-augmented germling vaccines in turkey poults challenged with Aspergillus fumigatus.
    Richard JL; Peden WM; Sacks JM
    Avian Dis; 1991; 35(1):93-9. PubMed ID: 2029265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection.
    Ben-Ami R; Lewis RE; Kontoyiannis DP
    Br J Haematol; 2010 Aug; 150(4):406-17. PubMed ID: 20618330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Pathogenesis of
    Gu X; Hua YH; Zhang YD; Bao DI; Lv J; Hu HF
    Pol J Microbiol; 2021 Mar; 70(1):3-11. PubMed ID: 33815522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.